InnoCan Pharma(TSE:INNO)
CA$1.65-0.17 (-9.34%)
TSE:INNO
InnoCan Pharma financials statements
CA$1.65
At close:-0.17 (-9.34%)
Want to see TSE:INNO full AI Analyst Report?
InnoCan Pharma (INNO) Income Statement
23 Followers
InnoCan Pharma Income Statement
Last quarter (Q2 2026), InnoCan Pharma's total revenue was $5.29M, a decrease of 24.56% from the same quarter last year. In Q2, InnoCan Pharma's net income was $-34.23K. See InnoCan Pharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Mar 25 | Mar 24 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| $ 26.61M | $ 29.44M | $ 13.66M | $ 2.56M | $ 196.00K | |
| $ 23.93M | $ 26.19M | $ 11.98M | $ 2.11M | $ 121.00K | |
| $ 25.19M | $ 27.43M | $ 8.18M | $ 8.37M | $ 7.60M | |
| Depreciation and Amortization | $ 42.00K | $ 35.00K | $ 33.00K | $ 35.00K | $ 43.00K |
| $ 130.00K | $ 961.00K | $ -3.77M | $ -3.85M | $ -10.04M | |
| $ -1.25M | $ -1.25M | $ 3.80M | $ -6.27M | $ -7.48M | |
| $ 1.34M | $ 2.17M | $ -7.84M | $ 2.38M | $ -2.61M | |
| $ 85.00K | $ 919.00K | $ -4.03M | $ -3.89M | $ -10.09M | |
| $ -1.12M | $ -1.83M | $ -4.70M | $ -3.89M | $ -10.06M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.25 | $ -0.42 | $ -1.19 | $ -1.01 | $ -2.91 |
| Diluted EPS | $ -0.25 | $ -0.42 | $ -1.19 | $ -1.01 | $ -2.91 |
| Weighted Average Shares Outstanding | 4.48M | 4.20M | 3.86M | 3.73M | 3.37M |
| Weighted Average Shares Outstanding (Diluted) | 4.48M | 4.20M | 3.86M | 3.73M | 3.37M |
Currency in USD
